Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger – Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1
Aim: The aim of this research was to evaluate the long-term outcome of pancreaticoduodenectomy (PD) versus other duodenopancreatic resections (non-PD) for the surgical treatment of the Zollinger–Ellison syndrome (ZES) in patients with multiple endocrine neoplasia type 1 (MEN1). Methods: Prospecti...
|Main Authors:||, , , , , ,|
|Online Access:||PDF Full Text|
No Tags, Be the first to tag this record!
|Summary:||Aim: The aim of this research was to evaluate the long-term outcome of pancreaticoduodenectomy
(PD) versus other duodenopancreatic resections (non-PD) for the surgical treatment of
the Zollinger–Ellison syndrome (ZES) in patients with multiple endocrine neoplasia type 1 (MEN1).
Methods: Prospectively recorded patients with biochemically confirmed MEN1-ZES who underwent
duodenopancreatic surgery were retrospectively analyzed in terms of clinical characteristics, complications,
cure rate, and long-term morbidity, including quality of life assessment (EORTC QLQ-C30).
Results: 35 patients (16 female, 19 male) with MEN1-ZES due to duodenopancreatic gastrinomas with
a median age of 42 (range 30–74) years were included. At the time of diagnosis, 28 (80%) gastrinomas
were malignant, but distant metastases were only present in one (3%) patient. Eleven patients (31.4%)
underwent pancreatoduodenectomy (PD) as the initial procedure, whereas 24 patients underwent
non-PD resections involving duodenotomy with gastrinoma excision, enucleation of the pNEN from
the head of the pancreas, and peripancreatic lymphadenectomy, either with or without distal pancreatectomy
(i.e., either Thompson procedure, n = 12, or DUODX, n = 12). There was no significant
difference in perioperative morbidity and mortality between the two groups (p � 0.05). One (9%)
patient of the PD group required reoperation for recurrent or metastatic ZES compared to eight
(22.8%) patients of the non-PD resection groups. After a median follow-up time of 134 months (range
6–480) nine of 11 (82%) patients in the PD group, two of 12 (16%) patients in the Thompson procedure
group, and three of 12 (25%) patients in the DUODX group had normal serum gastrin levels. In
addition, the global health QoLScore was better in the PD group (76.9) compared to the Thompson
procedure (57.4) and DUODX (59.5) groups. Conclusions: Initial PD seems to be the superior surgical
procedure for MEN1-ZES, resulting in a long-term cure rate of about 80%, fewer duodenopancreatic
reoperations, and an acceptable quality of life.
|Item Description:||Gefördert durch den Open-Access-Publikationsfonds der UB Marburg.|
|Physical Description:||15 Pages|